Intervention Review

Spironolactone for hypertension

  1. Josh Batterink2,
  2. Sarah N Stabler3,
  3. Aaron M Tejani1,*,
  4. Curt T Fowkes2

Editorial Group: Cochrane Hypertension Group

Published Online: 4 AUG 2010

Assessed as up-to-date: 10 MAR 2010

DOI: 10.1002/14651858.CD008169.pub2

How to Cite

Batterink J, Stabler SN, Tejani AM, Fowkes CT. Spironolactone for hypertension. Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD008169. DOI: 10.1002/14651858.CD008169.pub2.

Author Information

  1. 1

    Fraser Health Authority, Pharmacy Services, Burnaby, BC, Canada

  2. 2

    Northern Health Authority, Pharmacy, Prince George, BC, Canada

  3. 3

    University of BC, Faculty of Pharmaceutical Sciences, Vancouver, BC, Canada

*Aaron M Tejani, Pharmacy Services, Fraser Health Authority, 3935 Kincaid Street, Burnaby, BC, V5G 2X6, Canada.

Publication History

  1. Publication Status: New
  2. Published Online: 4 AUG 2010


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.